Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
Eagle Pharmicals提供苯达莫司汀知识产权组合的最新情况
United States Court Of Appeals For The Federal Circuit Affirmed The Previously Announced Decision By The United States District Court For The District Of Delaware Finding That Drug Applications Referencing Eagle Pharmaceuticals' Belrapzo (Bendamustine) Filed By Slayback Pharma And Apotex Did Not Infringe Eagle's Previously Issued '483 Patent
美国联邦巡回上诉法院确认了美国特拉华特区地方法院先前宣布的裁决，认定Slayback Pharma和Apotex提交的引用鹰制药公司Belrapzo（苯达莫司汀）的药物申请没有侵犯Eagle先前发布的'483专利